Shares of YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report) shot up 9.2% during mid-day trading on Friday . The company traded as high as $19.20 and last traded at $18.70. Approximately 308,695 shares changed hands during trading, an increase of 49% from the average daily volume of 207,254 shares. The stock had previously closed at $17.13.
YieldMax MRNA Option Income Strategy ETF Stock Performance
The company’s 50 day moving average price is $16.54 and its 200 day moving average price is $17.59.
About YieldMax MRNA Option Income Strategy ETF
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
Read More
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
